CME Group Inc. $CME Shares Purchased by Bank of Jackson Hole Trust

Bank of Jackson Hole Trust increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 15.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,532 shares of the financial services provider’s stock after acquiring an additional 209 shares during the period. Bank of Jackson Hole Trust’s holdings in CME Group were worth $422,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Diversified Trust Co acquired a new position in CME Group during the first quarter worth $278,000. Golden State Wealth Management LLC grew its holdings in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Avidian Wealth Enterprises LLC grew its holdings in CME Group by 8.8% in the first quarter. Avidian Wealth Enterprises LLC now owns 1,925 shares of the financial services provider’s stock valued at $511,000 after purchasing an additional 156 shares during the last quarter. Spinnaker Trust acquired a new stake in CME Group in the first quarter valued at $206,000. Finally, Koshinski Asset Management Inc. grew its holdings in CME Group by 1.4% in the first quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider’s stock valued at $934,000 after purchasing an additional 48 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director William R. Shepard bought 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CME. Raymond James Financial lowered their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and upped their target price for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Jefferies Financial Group lowered their target price on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 10th. TD Cowen upped their target price on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, October 23rd. Finally, Piper Sandler upped their target price on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $284.53.

CME Group Price Performance

NASDAQ:CME opened at $266.33 on Wednesday. The firm has a market cap of $95.98 billion, a price-to-earnings ratio of 25.81, a price-to-earnings-growth ratio of 4.58 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company’s 50-day moving average is $266.38 and its two-hundred day moving average is $272.08. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.68 EPS. Research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is 48.45%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.